{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T07:23:57Z","timestamp":1769153037482,"version":"3.49.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"South African National Research Foundation","award":["64767"],"award-info":[{"award-number":["64767"]}]},{"name":"South African National Research Foundation","award":["80825"],"award-info":[{"award-number":["80825"]}]}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.xphs.2019.02.006","type":"journal-article","created":{"date-parts":[[2019,2,25]],"date-time":"2019-02-25T10:16:10Z","timestamp":1551089770000},"page":"2349-2357","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Cocrystal and Salt Forms of an Imidazopyridazine Antimalarial Drug Lead"],"prefix":"10.1016","volume":"108","author":[{"given":"Terence J.","family":"Noonan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly","family":"Chibale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter M.","family":"Cheuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan A.","family":"Bourne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mino R.","family":"Caira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7572","key":"10.1016\/j.xphs.2019.02.006_bib1","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/nature15535","article-title":"The effect of malaria control on Plasmodium falciparum in Africa between 2000 and 2015","volume":"526","author":"Bhatt","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.xphs.2019.02.006_bib2","series-title":"World Malaria Report","year":"2017"},{"issue":"5","key":"10.1016\/j.xphs.2019.02.006_bib3","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1056\/NEJMoa0808859","article-title":"Artemisinin resistance in Plasmodium falciparum malaria","volume":"361","author":"Dondorp","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.xphs.2019.02.006_bib4","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1056\/NEJMc1612765","article-title":"Emergence of indigenous artemisinin-resistant Plasmodium falciparum in Africa","volume":"376","author":"Lu","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.xphs.2019.02.006_bib5","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1056\/NEJMoa1314981","article-title":"Spread of artemisinin resistance in Plasmodium falciparum malaria","volume":"371","author":"Ashley","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"8","key":"10.1016\/j.xphs.2019.02.006_bib6","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nm.4381","article-title":"Antimalarial drug resistance: linking Plasmodium falciparum parasite biology to the clinic","volume":"23","author":"Blasco","year":"2017","journal-title":"Nat Med"},{"issue":"6","key":"10.1016\/j.xphs.2019.02.006_bib7","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1021\/jm500098s","article-title":"Medicinal chemistry optimization of antiplasmodial imidazopyridazine hits from high throughput screening of a SoftFocus kinase library: part 1","volume":"57","author":"Le Manach","year":"2014","journal-title":"J\u00a0Med Chem"},{"issue":"10","key":"10.1016\/j.xphs.2019.02.006_bib8","doi-asserted-by":"crossref","first-page":"4533","DOI":"10.1128\/AAC.00519-09","article-title":"Improved murine model of malaria using Plasmodium falciparum competent strains and non-myelodepleted NOD-scid IL2R\u03b3null mice engrafted with human erythrocytes","volume":"53","author":"Jim\u00e9nez-D\u00edaz","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"issue":"21","key":"10.1016\/j.xphs.2019.02.006_bib9","doi-asserted-by":"crossref","first-page":"8839","DOI":"10.1021\/jm500887k","article-title":"Medicinal chemistry optimization of antiplasmodial imidazopyridazine hits from high throughput screening of a softfocus kinase library: part 2","volume":"57","author":"Le Manach","year":"2014","journal-title":"J\u00a0Med Chem"},{"issue":"3","key":"10.1016\/j.xphs.2019.02.006_bib10","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/S1367-5931(03)00055-3","article-title":"Profiling drug-like properties in discovery research","volume":"7","author":"Di","year":"2003","journal-title":"Curr Opin Chem Biol"},{"issue":"3","key":"10.1016\/j.xphs.2019.02.006_bib11","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1517\/17460441003605098","article-title":"Lipophilicity in drug discovery","volume":"5","author":"Waring","year":"2010","journal-title":"Expert Opin Drug Dis"},{"issue":"3","key":"10.1016\/j.xphs.2019.02.006_bib12","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1023\/A:1016212804288","article-title":"A\u00a0theoretical basis for a biopharmaceutic drug classification: the correlation of in\u00a0vitro drug product dissolution and in\u00a0vivo bioavailability","volume":"12","author":"Amidon","year":"1995","journal-title":"Pharm Res"},{"issue":"8","key":"10.1016\/j.xphs.2019.02.006_bib14","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/nrd1470","article-title":"Can the pharmaceutical industry reduce attrition rates?","volume":"3","author":"Kola","year":"2004","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"10.1016\/j.xphs.2019.02.006_bib15","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1124\/pr.112.005660","article-title":"Strategies to address low drug solubility in discovery and development","volume":"65","author":"Williams","year":"2013","journal-title":"Pharmacol Rev"},{"issue":"6","key":"10.1016\/j.xphs.2019.02.006_bib17","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1002\/jps.22434","article-title":"Coformer selection in pharmaceutical cocrystal development: a case study of a meloxicam aspirin cocrystal that exhibits enhanced solubility and pharmacokinetics","volume":"100","author":"Cheney","year":"2011","journal-title":"J\u00a0Pharm Sci"},{"issue":"9","key":"10.1016\/j.xphs.2019.02.006_bib18","doi-asserted-by":"crossref","first-page":"3769","DOI":"10.1002\/jps.22181","article-title":"Improved pharmacokinetics of AMG 517 through co-crystallization Part 1: comparison of two acids with corresponding amide co-crystals","volume":"99","author":"Stanton","year":"2010","journal-title":"J\u00a0Pharm Sci"},{"issue":"3","key":"10.1016\/j.xphs.2019.02.006_bib19","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1021\/cg0496540","article-title":"Pharmaceutical cocrystallization: engineering a remedy for caffeine hydration","volume":"5","author":"Trask","year":"2005","journal-title":"Cryst Growth Des"},{"issue":"38-39","key":"10.1016\/j.xphs.2019.02.006_bib20","doi-asserted-by":"crossref","first-page":"3905","DOI":"10.1002\/adma.200900533","article-title":"Improving mechanical properties of crystalline solids by cocrystal formation: new compressible forms of paracetamol","volume":"21","author":"Karki","year":"2009","journal-title":"Adv Mater"},{"key":"10.1016\/j.xphs.2019.02.006_bib21","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ijpharm.2018.10.062","article-title":"Improving solid-state properties of berberine chloride through forming a salt cocrystal with citric acid","volume":"554","author":"Lu","year":"2019","journal-title":"Int J Pharm"},{"issue":"37","key":"10.1016\/j.xphs.2019.02.006_bib22","doi-asserted-by":"crossref","first-page":"5486","DOI":"10.1039\/C8CE00787J","article-title":"Lack of dependence of mechanical properties of baicalein cocrystals on those of the constituent components","volume":"20","author":"Liu","year":"2018","journal-title":"CrystEngComm"},{"issue":"12","key":"10.1016\/j.xphs.2019.02.006_bib23","doi-asserted-by":"crossref","first-page":"3032","DOI":"10.1002\/asia.201300859","article-title":"Andrographolide: solving chemical instability and poor solubility by means of cocrystals","volume":"8","author":"Suresh","year":"2013","journal-title":"Chem Asian J"},{"key":"10.1016\/j.xphs.2019.02.006_bib24","series-title":"FDA approves SteglatroTM as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus","year":"2017"},{"key":"10.1016\/j.xphs.2019.02.006_bib25","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1039\/b207369m","article-title":"Mechanochemistry and co-crystal formation: effect of solvent on reaction kinetics","volume":"20","author":"Shan","year":"2002","journal-title":"Chem Commun"},{"issue":"3","key":"10.1016\/j.xphs.2019.02.006_bib26","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1021\/mp050099m","article-title":"Reaction crystallization of pharmaceutical molecular complexes","volume":"3","author":"Rodr\u00edguez-Hornedo","year":"2006","journal-title":"Mol Pharm"},{"issue":"3","key":"10.1016\/j.xphs.2019.02.006_bib27","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1107\/S002188980600731X","article-title":"Mercury: visualization and analysis of crystal structures","volume":"39","author":"Macrae","year":"2006","journal-title":"J\u00a0Appl Crystallogr"},{"issue":"2","key":"10.1016\/j.xphs.2019.02.006_bib28","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1107\/S0021889807067908","article-title":"Mercury CSD 2.0\u2013new features for the visualization and investigation of crystal structures","volume":"41","author":"Macrae","year":"2008","journal-title":"J\u00a0Appl Crystallogr"},{"key":"10.1016\/j.xphs.2019.02.006_bib29","series-title":"APEX2. Version 1.0-27","year":"2005"},{"key":"10.1016\/j.xphs.2019.02.006_bib30","series-title":"Program SAINT, Version 7.60a","year":"2008"},{"key":"10.1016\/j.xphs.2019.02.006_bib31","series-title":"SADABS, Program for Empirical Absorption Correction of Area Detector Data","author":"Sheldrick","year":"1997"},{"key":"10.1016\/j.xphs.2019.02.006_bib32","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S1472-7862(02)00030-8","article-title":"X-Seed\u2014a software tool for supramolecular crystallography","volume":"1","author":"Barbour","year":"2001","journal-title":"J\u00a0Supramol Chem"},{"issue":"1","key":"10.1016\/j.xphs.2019.02.006_bib33","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1107\/S0108767307043930","article-title":"A\u00a0short history of SHELX","volume":"64","author":"Sheldrick","year":"2008","journal-title":"Acta Crystallogr A"},{"key":"10.1016\/j.xphs.2019.02.006_bib34","series-title":"PerkinElmer Spectrum. Version 10.03.02","year":"2011"},{"key":"10.1016\/j.xphs.2019.02.006_bib35","series-title":"THASS GmbH, DSC XP-10. Version 3.3.0.7(D)","year":"2003"},{"key":"10.1016\/j.xphs.2019.02.006_bib36","series-title":"TA Instruments, Universal Analysis 2000 for Windows. Version 4.7A","year":"2009"},{"key":"10.1016\/j.xphs.2019.02.006_bib37","series-title":"Agilent Technology. OpenLAB CDS ChemStation Edition. Version A.01.06.111","year":"2018"},{"issue":"5","key":"10.1016\/j.xphs.2019.02.006_bib38","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1021\/cg300180b","article-title":"Establishing supramolecular control over solid-state architectures: a simple mix and match strategy","volume":"12","author":"Aaker\u00f6y","year":"2012","journal-title":"Cryst Growth Des"},{"issue":"2","key":"10.1016\/j.xphs.2019.02.006_bib39","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1039\/C4NJ01324G","article-title":"Molecular electrostatic potential dependent selectivity of hydrogen bonding","volume":"39","author":"Aaker\u00f6y","year":"2015","journal-title":"New J Chem"},{"issue":"2","key":"10.1016\/j.xphs.2019.02.006_bib40","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1021\/cg201510n","article-title":"Cocrystal systems of pharmaceutical interest: 2010","volume":"12","author":"Brittain","year":"2012","journal-title":"Cryst Growth Des"},{"issue":"6","key":"10.1016\/j.xphs.2019.02.006_bib41","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1021\/jp911694r","article-title":"Density functional study of the proton transfer effect on vibrations of strong (short) intermolecular O\u2212 H\u00b7\u00b7\u00b7 N\/O\u2212\u00b7\u00b7\u00b7 H\u2212 N+ hydrogen bonds in aprotic solvents","volume":"114","author":"Kong","year":"2010","journal-title":"J\u00a0Phys Chem A"},{"key":"10.1016\/j.xphs.2019.02.006_bib42","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.molstruc.2012.11.011","article-title":"Organic salts of guanazole \u2013 seeking for new materials for second harmonic generation","volume":"1044","author":"Matulkov\u00e1","year":"2013","journal-title":"J\u00a0Mol Struct"},{"issue":"3","key":"10.1016\/j.xphs.2019.02.006_bib43","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1021\/mp0601345","article-title":"The salt\u2212 cocrystal continuum: the influence of crystal structure on ionization state","volume":"4","author":"Childs","year":"2007","journal-title":"Mol Pharm"},{"issue":"2","key":"10.1016\/j.xphs.2019.02.006_bib44","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1021\/cg050391z","article-title":"2-Acetaminopyridine: a highly effective cocrystallizing agent","volume":"6","author":"Aaker\u00f6y","year":"2006","journal-title":"Cryst Growth Des"},{"issue":"2","key":"10.1016\/j.xphs.2019.02.006_bib45","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1107\/S0108768189012929","article-title":"Graph-set analysis of hydrogen-bond patterns in organic crystals","volume":"46","author":"Etter","year":"1990","journal-title":"Acta Crystallogr B Struct Sci"},{"issue":"1","key":"10.1016\/j.xphs.2019.02.006_bib47","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1021\/cg901010v","article-title":"Effects of crystal form on solubility and pharmacokinetics: a crystal engineering case study of lamotrigine","volume":"10","author":"Cheney","year":"2009","journal-title":"Cryst Growth Des"},{"issue":"10","key":"10.1016\/j.xphs.2019.02.006_bib48","doi-asserted-by":"crossref","first-page":"3856","DOI":"10.1021\/cg800173d","article-title":"Physicochemical properties of pharmaceutical co-crystals: a case study of ten AMG 517 co-crystals","volume":"8","author":"Stanton","year":"2008","journal-title":"Cryst Growth Des"},{"issue":"8","key":"10.1016\/j.xphs.2019.02.006_bib49","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1007\/s11095-006-9032-3","article-title":"Use of a glutaric acid cocrystal to improve oral bioavailability of a low solubility API","volume":"23","author":"McNamara","year":"2006","journal-title":"Pharm Res"},{"issue":"41","key":"10.1016\/j.xphs.2019.02.006_bib50","doi-asserted-by":"crossref","first-page":"13335","DOI":"10.1021\/ja048114o","article-title":"Crystal engineering approach to forming cocrystals of amine hydrochlorides with organic acids. Molecular complexes of fluoxetine hydrochloride with benzoic, succinic, and fumaric acids","volume":"126","author":"Childs","year":"2004","journal-title":"J\u00a0Am Chem Soc"},{"issue":"1","key":"10.1016\/j.xphs.2019.02.006_bib51","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ijpharm.2012.11.028","article-title":"Use of pharmaceutical salts and cocrystals to address the issue of poor solubility","volume":"453","author":"Elder","year":"2013","journal-title":"Int J Pharm"},{"issue":"7","key":"10.1016\/j.xphs.2019.02.006_bib52","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1002\/jps.22502","article-title":"Improved pharmacokinetics of AMG 517 through co-crystallization part 2: analysis of 12 carboxylic acid co-crystals","volume":"100","author":"Stanton","year":"2011","journal-title":"J\u00a0Pharm Sci"},{"issue":"4","key":"10.1016\/j.xphs.2019.02.006_bib53","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1021\/acs.cgd.6b01894","article-title":"Exploring solid state diversity and solution characteristics in a fluorine-containing drug Riluzole","volume":"17","author":"Mondal","year":"2017","journal-title":"Cryst Growth Des"},{"issue":"47","key":"10.1016\/j.xphs.2019.02.006_bib54","doi-asserted-by":"crossref","first-page":"17048","DOI":"10.1021\/ja907674c","article-title":"Using cocrystals to systematically modulate aqueous solubility and melting behavior of an anticancer drug","volume":"131","author":"Aaker\u00f6y","year":"2009","journal-title":"J\u00a0Am Chem Soc"},{"issue":"7","key":"10.1016\/j.xphs.2019.02.006_bib55","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1039\/C2CE06507J","article-title":"Co-crystals of the antiretroviral nevirapine: crystal structures, thermal analysis and dissolution behaviour","volume":"14","author":"Caira","year":"2012","journal-title":"CrystEngComm"},{"issue":"26","key":"10.1016\/j.xphs.2019.02.006_bib56","doi-asserted-by":"crossref","first-page":"5870","DOI":"10.1039\/C4CE00206G","article-title":"Altering physical properties of pharmaceutical co-crystals in a systematic manner","volume":"16","author":"Aaker\u00f6y","year":"2014","journal-title":"CrystEngComm"},{"issue":"19","key":"10.1016\/j.xphs.2019.02.006_bib57","doi-asserted-by":"crossref","first-page":"3591","DOI":"10.1039\/C5CE00102A","article-title":"Co-crystals and molecular salts of carboxylic acid\/pyridine complexes: can calculated pKa's predict proton transfer? A case study of nine complexes","volume":"17","author":"Lemmerer","year":"2015","journal-title":"CrystEngComm"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354919300917?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354919300917?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,21]],"date-time":"2019-06-21T08:41:10Z","timestamp":1561106470000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354919300917"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":54,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S0022354919300917"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2019.02.006","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cocrystal and Salt Forms of an Imidazopyridazine Antimalarial Drug Lead","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2019.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}